Ever since the news came out about the recent Stanford study that involves drilling into a patient's skull and inserting stem cells, more and more folks can't wait to try it out. While the results are promising, it's still a little early in the research process to say this is safe and effective on a large scale.
This week, I welcome back Dr. Nirav H. Shah to the program to help demystify this new treatment, explain how the procedure works, and talk about the future of stem cell therapy for stroke patients.
A key thing to keep in mind is that we are talking about adult stem cells -- not embryonic or fetal stem cells. Since these are adult stem cells, that means this has nothing to do with the ethical concerns around abortion. The stem cell being used in the trials at Stanford and the University of Miami all come from the patients themselves.
Dr. Nirav H. Shah a fellowship trained neurologist and sub-specialist in cerebrovascular and stroke medicine with board certifications in t: neurology, stroke medicine, carotid neurosonology, transcranial doppler ultrasound, and neuroimaging.
He is a practicing neurohospitalist and stroke medical director at Swedish Medical Center in Seattle. Academically, he is interested in emergent and critical care neurology research and is an associate editor for The Neurohospitalist, a peer-reviewed journal. He enjoys mentoring trainees and collaborating on publications and conference presentations.
Outside of clinical care Dr Shah is collaborating with experts to develop scalable technologies capable of ameliorating healthcare’s challenges. He consults with startups and investors to develop technologies and devices so that one day they are available to his patients. He has worked with companies to meet FDA regulations for approval as well as to help them understand the provider perspective of product-market fit.
Dr. Shah is also the CEO and Founder of Sentinel Healthcare. He is also a passionate traveler and photographer.
Geekwire recently wrote about Sentinel's new product and quoted CEO Dr. Shah:
On Thursday, Shah’s idea took a step forward with the launch of Sentinel Healthcare, a startup he founded make this platform a reality. The company announced partnerships with five clinics in Arizona, Tennessee and Florida to implement its first product, a software that helps patients manage hypertension.
But Shah, the company’s co-founder and CEO, said Sentinel has ambitions far beyond that one condition. The startup has already taken first place at the Seattle Angel Conference and is setting itself up to be a platform for any number of health conditions that could be tracked with IoT (internet of things) devices.
You can read the rest of the article here.
Back in episode 7, I talked about how to open a beer or soda bottle with one hand. This week, I have an even better solution -- the Gropener.
This unfortunately named item is a one-handed bottle opener. Put it on the lid, squeeze the neck of the bottle, and the lid pops right off. If your doctor has cleared you to drink bottled beverages, I highly recommend the Gropener.
Nirav's previous appearance | |
Nirav H Shah on LinkedIn | |
Nirav H Shah at Swedish | https://www.swedish.org/swedish-physicians/profile.aspx?name=nirav+h+shah&id=271893 |
Nirav on Twitter | |
The Neurohospitalist | |
Nirav’s Photography | |
Sentinel Healthcare | |
Sentinel Healthcare on Geekwire | |
Stanford Stem Cell Study Article | |
Stanford Research email | stemcellstudy@stanford.edu |
University of Miami Stem Cell Study Article | |
Peter Levine on Stem Cell Therapy | http://recoverfromstroke.blogspot.com/2018/05/stem-cell-treatment-for-stroke-not-yet.html |
Gropener on Amazon | https://www.amazon.com/gp/product/B00PAYRF04/ref=oh_aui_detailpage_o04_s00?ie=UTF8&psc=1 |
Previous Bottle Opening hack | |
Bill on Take 5 | |
Strokecast on Facebook |